Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients with Advanced Lung Adenocarcinoma

Dataset ID Technology Samples
EGAD00001006287 HiSeq X Ten,Illumina HiSeq 4000 12

Dataset Description

NGS data of 12 patients enrolled in the Chinese Patient Assistance Program from multiple centers who received pemetrexed alone or combined with platinum as initial chemotherapy and continued pemetrexed maintenance therapy for advanced lung adenocarcinoma from November 2014 to June 2017.

Who controls access to this dataset

For each dataset that requires controlled access, there is a corresponding Data Access Committee (DAC) who determine access permissions. Access to actual data files is not managed by the EGA. If you need to request access to this data set, please contact:

Agreement for accessing data of NGS based ctDNA tests
Contact person: Xue Wu
Email: xue [dot] wu [at] geneseeq [dot] com
More details: EGAC00001000598


You don't have access to the download section.